Cycloheximide selectively inhibits double-stranded reovirus RNA synthesis when added late in infection, suggesting that double-stranded RNA synthesis requires prior synthesis of a new protein with rapid turnover.
Answers are grounded in this paper and cite their sources.
Preclinical data warrant caution against clinical extrapolation; leaves open whether labile proteins drive dsRNA synthesis across viruses or hosts.
Cycloheximide, at a concentration of 10 mug/ml, rapidly blocked protein synthesis in L cells infected with reovirus. When the drug was added before 5 hr postinfection, synthesis of both single- and double-stranded varieties of virus-specific ribonucleic acid (RNA), which normally commences between 6 and 7 hr after infection, was blocked. When the cycloheximide was added at 9 hr after infection, uptake of uridine-H(3) into RNA, for the succeeding 6 hr at least, was similar to that of an infected culture without the drug. This latter uptake of uridine-H(3) in the presence of cycloheximide was largely into single-stranded RNA, since double-stranded RNA synthesis was rapidly and markedly inhibited by the cycloheximide. Single-stranded RNA formed in the presence of cycloheximide was found not to be a precursor of viral progeny, double-stranded RNA. Synthesis of double-stranded RNA in the infected cell probably requires prior synthesis of a new protein, which has a rapid rate of turnover. The possibility that formation of single-stranded RNA is preceded by synthesis of a second new protein is discussed.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: